This retrospective cohort study evaluates clinical, surgical, and prosthetic factors associated with early and mid-term outcomes of immediate implant placement in the anterior maxilla. The primary objective is to identify predictors of implant survival and complications (e.g., infection, soft-tissue dehiscence, esthetic failure) within 12 months following placement. Secondary objectives include assessment of peri-implant marginal bone loss, prosthetic complications, and esthetic outcomes (pink esthetic score).
Who can participate
Age range21 Years – 55 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* flapless immediately placed implants in esthetic zone with 3 years follow up CBCT,
* presence of immediate postoperative CBCT,
* initial intact thick gingival biotype with at least 2 mm band of keratinized tissue
* thin intact labial bone plate (\< 1mm) extending 7 mm apically assessed by CBCT with good apical bone
* patients who had provided an informed consent.
Exclusion Criteria:
* patients with medical conditions that would compromise the surgical procedures, uncontrolled diabetes mellitus, taking IV bis-phosphonates for treatment of osteoporosis
* patients with active infection related at the site of implant and patients with untreated active periodontal diseases.